Health-Related Quality of Life of Moroccan COVID-19 Survivors: A Case-Control Study.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
20 07 2022
Historique:
received: 24 05 2022
revised: 01 07 2022
accepted: 05 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Background: Research on COVID-19 has mostly focused on transmission, mortality and morbidity associated with the virus. However, less attention has been given to its impact on health-related quality of life (HRQoL) of patients with COVID-19. Therefore, this study aimed to determine the demographic and clinical risk factors associated with COVID-19 and evaluate its impact on the HRQoL of COVID-19 survivors. Methods: A case-control study was carried out between September 2021 and March 2022 on 1105 participants. A total of 354 were COVID-19 survivors and 751 were the control group. The HRQoL was assessed using both EQ-5D-5L and SF-6D generic instruments. Results: The average age of all participants was 56.17 ± 15.46. Older age, urban area, tobacco use, presence of chronic diseases especially type 1 diabetes, kidney and cardiovascular diseases were significantly associated with COVID-19. The COVID-19 survivors had significantly lower HRQoL (EQ-VAS = 50.89) compared to the control group (EQ-VAS = 63.36) (p-value < 0.0001). Pain/ discomfort and anxiety/depression were the most negatively affected by COVID-19 (p-value < 0.0001). Conclusions: The findings from this study could help healthcare professionals and policy makers to better understand the HRQoL sequelae among the COVID-19 survivors and contribute to develop tailored interventions.

Identifiants

pubmed: 35886656
pii: ijerph19148804
doi: 10.3390/ijerph19148804
pmc: PMC9317197
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Public Health. 2020 Dec;189:129-134
pubmed: 33227595
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Vaccine. 2021 Feb 12;39(7):1157-1164
pubmed: 33483216
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
Psychiatry Res. 2020 Sep;291:113264
pubmed: 32622172
Nutrients. 2020 Jul 19;12(7):
pubmed: 32707724
Front Immunol. 2020 Oct 27;11:579220
pubmed: 33193377
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Clinicoecon Outcomes Res. 2022 Apr 28;14:293-307
pubmed: 35509962
Int J Epidemiol. 2020 Oct 1;49(5):1454-1467
pubmed: 32814959
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Econ Disaster Clim Chang. 2020;4(3):453-479
pubmed: 32838120
J Affect Disord Rep. 2021 Dec;6:100248
pubmed: 34642678
Clin Cardiol. 2021 Feb;44(2):276-283
pubmed: 33382482
Epidemiol Infect. 2020 Jun 10;148:e114
pubmed: 32517822
Diagnosis (Berl). 2020 May 26;7(2):91-96
pubmed: 32352401
J Gen Intern Med. 2020 May;35(5):1545-1549
pubmed: 32133578
JAMA. 2003 Jun 4;289(21):2801-9
pubmed: 12734147
Data Brief. 2020 Oct;32:106239
pubmed: 32868996
Int J Environ Res Public Health. 2020 Nov 16;17(22):
pubmed: 33207689
Med Care. 2020 Jun;58(6):557-565
pubmed: 32412942
J Med Econ. 2021 Jan-Dec;24(1):308-317
pubmed: 33555956
Int J Surg. 2020 Jun;78:185-193
pubmed: 32305533
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
J Formos Med Assoc. 2020 May;119(5):982-989
pubmed: 32307322
Eur J Phys Rehabil Med. 2020 Jun;56(3):323-326
pubmed: 32293817
PLoS One. 2020 Dec 11;15(12):e0243882
pubmed: 33306721
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
BMJ Open. 2021 May 25;11(5):e047680
pubmed: 34035105
Diabet Med. 2021 May;38(5):e14547
pubmed: 33615546
Front Med (Lausanne). 2020 Sep 04;7:552002
pubmed: 33015108
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4539-4547
pubmed: 32373993
Res Social Adm Pharm. 2020 Dec;16(12):1754-1759
pubmed: 32057690
Expert Rev Anti Infect Ther. 2021 Jul;19(7):877-888
pubmed: 33306423
Am J Infect Control. 2021 Feb;49(2):238-246
pubmed: 32659414
Lancet Infect Dis. 2021 Jan;21(1):20-21
pubmed: 33248473
J Psychiatr Res. 2021 Nov 22;145:118-124
pubmed: 34894521
J Thromb Thrombolysis. 2020 Jul;50(1):43-53
pubmed: 32338320
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
J Infect Public Health. 2020 Dec;13(12):1833-1839
pubmed: 32788073
Int J Soc Psychiatry. 2020 Jun;66(4):317-320
pubmed: 32233719
Osong Public Health Res Perspect. 2020 Oct;11(5):296-302
pubmed: 33117634
Pediatr Pulmonol. 2020 Oct;55(10):2565-2575
pubmed: 32725955
Mol Metab. 2020 Sep;39:101044
pubmed: 32585364

Auteurs

Asmaa Azizi (A)

Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26000, Morocco.

Doha Achak (D)

Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26000, Morocco.

Elmadani Saad (E)

Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26000, Morocco.

Abderraouf Hilali (A)

Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26000, Morocco.

Chakib Nejjari (C)

International School of Public Health, Mohammed VI University of Health Sciences, Casablanca 82403, Morocco.

Mohamed Khalis (M)

International School of Public Health, Mohammed VI University of Health Sciences, Casablanca 82403, Morocco.

Ibtissam Youlyouz-Marfak (I)

Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26000, Morocco.

Abdelghafour Marfak (A)

Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26000, Morocco.
National School of Public Health, Ministry of Health, Rabat 10000, Morocco.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH